333 related articles for article (PubMed ID: 28899628)
1. A novel approach to a rabies vaccine based on a recombinant single-cycle flavivirus vector.
Giel-Moloney M; Rumyantsev AA; David F; Figueiredo M; Feilmeier B; Mebatsion T; Parrington M; Kleanthous H; Pugachev KV
Vaccine; 2017 Dec; 35(49 Pt B):6898-6904. PubMed ID: 28899628
[TBL] [Abstract][Full Text] [Related]
2. Application of replication-defective West Nile virus vector to non-flavivirus vaccine targets.
Giel-Moloney M; Vaine M; Zhang L; Parrington M; Gajewska B; Vogel TU; Pougatcheva SO; Duan X; Farrell T; Ustyugova I; Phogat S; Kleanthous H; Pugachev KV
Hum Vaccin Immunother; 2017 Dec; 13(12):2982-2986. PubMed ID: 28925795
[TBL] [Abstract][Full Text] [Related]
3. Newcastle disease virus-vectored rabies vaccine is safe, highly immunogenic, and provides long-lasting protection in dogs and cats.
Ge J; Wang X; Tao L; Wen Z; Feng N; Yang S; Xia X; Yang C; Chen H; Bu Z
J Virol; 2011 Aug; 85(16):8241-52. PubMed ID: 21632762
[TBL] [Abstract][Full Text] [Related]
4. Genetically modified rabies virus ERA strain is safe and induces long-lasting protective immune response in dogs after oral vaccination.
Shuai L; Feng N; Wang X; Ge J; Wen Z; Chen W; Qin L; Xia X; Bu Z
Antiviral Res; 2015 Sep; 121():9-15. PubMed ID: 26093157
[TBL] [Abstract][Full Text] [Related]
5. Immune modulating effect by a phosphoprotein-deleted rabies virus vaccine vector expressing two copies of the rabies virus glycoprotein gene.
Cenna J; Tan GS; Papaneri AB; Dietzschold B; Schnell MJ; McGettigan JP
Vaccine; 2008 Nov; 26(50):6405-14. PubMed ID: 18804506
[TBL] [Abstract][Full Text] [Related]
6. A recombinant canine distemper virus expressing a modified rabies virus glycoprotein induces immune responses in mice.
Li Z; Wang J; Yuan D; Wang S; Sun J; Yi B; Hou Q; Mao Y; Liu W
Virus Genes; 2015 Jun; 50(3):434-41. PubMed ID: 25764477
[TBL] [Abstract][Full Text] [Related]
7. A new rabies vaccine based on a recombinant ORF virus (parapoxvirus) expressing the rabies virus glycoprotein.
Amann R; Rohde J; Wulle U; Conlee D; Raue R; Martinon O; Rziha HJ
J Virol; 2013 Feb; 87(3):1618-30. PubMed ID: 23175365
[TBL] [Abstract][Full Text] [Related]
8. Immunogenicity and safety of recombinant rabies viruses used for oral vaccination of stray dogs and wildlife.
Faber M; Dietzschold B; Li J
Zoonoses Public Health; 2009 Aug; 56(6-7):262-9. PubMed ID: 19486317
[TBL] [Abstract][Full Text] [Related]
9. A novel rabies vaccine based on a recombinant parainfluenza virus 5 expressing rabies virus glycoprotein.
Chen Z; Zhou M; Gao X; Zhang G; Ren G; Gnanadurai CW; Fu ZF; He B
J Virol; 2013 Mar; 87(6):2986-93. PubMed ID: 23269806
[TBL] [Abstract][Full Text] [Related]
10. A single immunization with a recombinant canine adenovirus expressing the rabies virus G protein confers protective immunity against rabies in mice.
Li J; Faber M; Papaneri A; Faber ML; McGettigan JP; Schnell MJ; Dietzschold B
Virology; 2006 Dec 5-20; 356(1-2):147-54. PubMed ID: 16938327
[TBL] [Abstract][Full Text] [Related]
11. Genetically modified rabies virus-vectored Ebola virus disease vaccines are safe and induce efficacious immune responses in mice and dogs.
Shuai L; Wang X; Wen Z; Ge J; Wang J; Zhao D; Bu Z
Antiviral Res; 2017 Oct; 146():36-44. PubMed ID: 28822816
[TBL] [Abstract][Full Text] [Related]
12. Recombinant canine distemper virus serves as bivalent live vaccine against rabies and canine distemper.
Wang X; Feng N; Ge J; Shuai L; Peng L; Gao Y; Yang S; Xia X; Bu Z
Vaccine; 2012 Jul; 30(34):5067-72. PubMed ID: 22698451
[TBL] [Abstract][Full Text] [Related]
13. Infectivity of attenuated poxvirus vaccine vectors and immunogenicity of a raccoonpox vectored rabies vaccine in the Brazilian Free-tailed bat (Tadarida brasiliensis).
Stading BR; Osorio JE; Velasco-Villa A; Smotherman M; Kingstad-Bakke B; Rocke TE
Vaccine; 2016 Oct; 34(44):5352-5358. PubMed ID: 27650872
[TBL] [Abstract][Full Text] [Related]
14. Glycoprotein from street rabies virus BD06 induces early and robust immune responses when expressed from a non-replicative adenovirus recombinant.
Wang S; Sun C; Zhang S; Zhang X; Liu Y; Wang Y; Zhang F; Wu X; Hu R
Arch Virol; 2015 Sep; 160(9):2315-23. PubMed ID: 26143474
[TBL] [Abstract][Full Text] [Related]
15. Rhabdovirus-based vaccine platforms against henipaviruses.
Kurup D; Wirblich C; Feldmann H; Marzi A; Schnell MJ
J Virol; 2015 Jan; 89(1):144-54. PubMed ID: 25320306
[TBL] [Abstract][Full Text] [Related]
16. A rabies virus vectored severe fever with thrombocytopenia syndrome (SFTS) bivalent candidate vaccine confers protective immune responses in mice.
Tian L; Yan L; Zheng W; Lei X; Fu Q; Xue X; Wang X; Xia X; Zheng X
Vet Microbiol; 2021 Jun; 257():109076. PubMed ID: 33957572
[TBL] [Abstract][Full Text] [Related]
17. A recombinant human adenovirus vaccine against rabies.
Prevec L; Campbell JB; Christie BS; Belbeck L; Graham FL
J Infect Dis; 1990 Jan; 161(1):27-30. PubMed ID: 2295855
[TBL] [Abstract][Full Text] [Related]
18. Biological and immunogenic properties of rabies virus glycoprotein expressed by canine herpesvirus vector.
Xuan X; Tuchiya K; Sato I; Nishikawa Y; Onoderaz Y; Takashima Y; Yamamoto A; Katsumata A; Iwata A; Ueda S; Mikami T; Otsuka H
Vaccine; 1998; 16(9-10):969-76. PubMed ID: 9682345
[TBL] [Abstract][Full Text] [Related]
19. Protection of non-human primates against rabies with an adenovirus recombinant vaccine.
Xiang ZQ; Greenberg L; Ertl HC; Rupprecht CE
Virology; 2014 Feb; 450-451():243-9. PubMed ID: 24503087
[TBL] [Abstract][Full Text] [Related]
20. A simian-adenovirus-vectored rabies vaccine suitable for thermostabilisation and clinical development for low-cost single-dose pre-exposure prophylaxis.
Wang C; Dulal P; Zhou X; Xiang Z; Goharriz H; Banyard A; Green N; Brunner L; Ventura R; Collin N; Draper SJ; Hill AVS; Ashfield R; Fooks AR; Ertl HC; Douglas AD
PLoS Negl Trop Dis; 2018 Oct; 12(10):e0006870. PubMed ID: 30372438
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]